Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Endomimetics Awarded $300 Thousand Grant for Novel 3D in vitro Atherosclerosis Model

Oct 10, 2024•over 1 year ago

Contract Type

partnership

BirminghamBiotechnologyHealth Care

Description

Endomimetics has been awarded a $300 thousand Phase I Small Business Innovation Research (SBIR) grant to support automation and evaluation of a novel 3D in vitro functional assay for use in atherosclerosis drug discovery and development. The grant will support the automation and large-scale fabrication of a three-layer nanomatrix vascular sheet with atherosclerosis (VSA) functional assay, along with its evaluation for use in drug efficacy and safety research.

Company Information

Company

Endomimetics

Location

Birmingham, Alabama, United States

About

Endomimetics is the developer of Bionanomatrix™, a peptide-based biomaterial used to promote healing and improve outcomes following medical device implantation and other procedures.

Predictive Intelligence
Strategic

ML-powered predictions for Endomimetics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.